Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases
โ Scribed by Cheng, Jun ;Slavin, Richard E. ;Gallagher, Jennifer A. ;Zhu, Guojing ;Biehl, Thomas R. ;Swanstrom, Lee L. ;Hansen, Paul D.
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 430 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0944-1166
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We previously demonstrated an association between vascular endothelial growth factor (VEGF), vessel counts and metastasis in human colon cancer specimens. Mutant p53 has been implicated in the regulation of angiogenesis. Immunohistochemical detection of p53 protein has been associated with p53 gene
Eicosapentaenoic acid (EPA; 20:5, n-3) can restrain tumor growth and metastasis in vivo; however, the mechanism of its antitumor effect is still not fully understood. Angiogenesis is a crucial process for tumor growth and metastasis and inhibition of tumor angiogenesis can suppress tumor growth and
Vascular endothelial growth factor (VEGF) is a potent angiogenic polypeptide that activates 2 distinct high-affinity tyrosine kinase receptors, flk-1/KDR and flt-1. In the present study, we characterized the expression of VEGF and its receptors flk-1/KDR and flt-1 in the normal human pancreas and in